Gustave Roussy Selects TrialMaster EDC to Support Cancer Research
FORT LAUDERDALE, FL., July 05, 2017 (GLOBE NEWSWIRE)-Gustave Roussy, the cancer research institute in Europe, has selected TrialMaster electronic data capture (EDC) technology from OmniComm Systems, Inc., a global provider of clinical data management technology. OmniComm’s TrialMaster will support Gustave Roussy-sponsored clinical trials in oncology that are handled and analyzed by Gustave Roussy’s biostatistics and epidemiology unit. Gustave Roussy focuses on patient care, research, and teaching for all types of cancer.
TrialMaster was chosen because of certain features, including the ability to build studies, adeptness in query management workflow, intuitive interface, monitoring and centralized source review, eLearning modules, exporting abilities, and the range of report types.
“To have an institution as prestigious as Gustave Roussy select TrialMaster is a real testament to the quality, flexibility and scalability of both our EDC technology and our business operations. Moreover, we are incredibly proud to have been selected as their EDC partner,” said Kuno van der Post, OmniComm’s chief commercial officer. “TrialMaster has seen a great deal of well-publicized success over the last 18 months within the academic sector. Coupled with our deployments over that same time period in both pharmacompanies and CROs, it adds up to an achievement that cannot be emulated by many of the EDC systems available today.”
Contact Info
Kuno van der Post
OmniComm Systems, Inc.
+1.954.473.1254
KVanderPost@omnicomm.com
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
